Edison NJ 急性髓系白血病临床试验
20项针对 急性髓系白血病的研究正在 Edison及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
招募中1 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距离 3 英里
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 距离 15 英里
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
招募中2 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距离 3 英里
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 距离 15 英里
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距离 3 英里
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 距离 15 英里
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
招募中2 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距离 3 英里
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 距离 15 英里
A Study of CRD3874-SI in People With Leukemia
招募中1 期
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 距离 15 英里
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
招募中2 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距离 3 英里
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 距离 15 英里
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
招募中2 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距离 3 英里
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 距离 15 英里
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
招募中3 期
- Saint Peter's University Hospital, New Brunswick · 距离 3 英里
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 距离 3 英里
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Saint Peter's University Hospital, New Brunswick · 距离 3 英里
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 距离 3 英里
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
招募中3 期
- Rutgers Biomedical and Health Sciences, New Brunswick · 距离 3 英里
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
招募中2 期
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 距离 15 英里
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · 距离 3 英里
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)
招募中1 期
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · 距离 15 英里
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
招募中1 期
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 距离 15 英里
A Study of Revumenib and Mezigdomide in People With Leukemia
招募中1/2 期
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 距离 15 英里
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
招募中1 期
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 距离 15 英里
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
招募中1/2 期
- Rutgers Cancer Institute of New Jersey, New Brunswick · 距离 3 英里
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- Rutgers Cancer Institute, New Brunswick · 距离 3 英里
A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia
招募中1 期
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · 距离 15 英里
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)
招募中2 期
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · 距离 15 英里
其他城市的 急性髓系白血病试验
- Houston, TX85 项研究
- New York City, NY51 项研究
- Boston, MA44 项研究
- Baldwin Park, CA40 项研究
- Seattle, WA40 项研究
- Columbus, OH35 项研究
- Philadelphia, PA34 项研究
- Durham, NC33 项研究
- Atlanta, GA30 项研究
- Tampa, FL29 项研究
- Chicago, IL26 项研究
- Portland, OR25 项研究
Edison的其他研究
- 乳腺癌68 项研究
- 非小细胞肺癌47 项研究
- 癌症（所有类型）33 项研究
- 前列腺癌29 项研究
- 结直肠癌23 项研究
- 肺癌23 项研究
- 多发性骨髓瘤22 项研究
- 膀胱癌21 项研究
- 转移性癌症20 项研究
- 卵巢癌20 项研究
- 子宫内膜癌19 项研究
- 尿路上皮（移行细胞）癌18 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。